The GLP is committed to full transparency. Download and review our 2019 Annual Report

Is ADHD actually a sleep disorder?

| | June 2, 2017
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Could ADHD [be] a type of sleep disorder? After all, the brain pathways involved in paying attention have also been linked to sleep. And there’s some evidence of similarly disrupted patterns of chemical signalling in the brains of people with sleep disorders and ADHD.

This idea inspired Eric Konofal at Robert-Debré Hospital in Paris to try using a drug for narcolepsy and excessive daytime sleepiness to treat ADHD.

In their clinical trial, Konofal and his colleagues gave either mazindol or a placebo to 85 adults aged between 18 and 65, all of whom had previously been diagnosed with ADHD. Within two weeks, ADHD symptoms had reduced by more than 50 per cent in just over half of those who tried the drug.

These results are better than those in trials using conventional ADHD drugs, such as Ritalin and Adderall, says Daryl Efron at Murdoch Childrens Research Institute in Melbourne.

However, although mazindol improved many ADHD symptoms, it did not boost the quality of the volunteers’ sleep, nor reduce the daytime sleepiness they experienced.

[Read the full study here (behind paywall)]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Is ADHD a sleep disorder? Stimulant drug improves symptoms

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend